v3.25.3
Segment information
 9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
Segment information

Note 8. Segment information

 

We report segment information based on ASC 280 Segment Reporting, which defines operating segments as components of a company that engage in activities from which it may recognize revenues and incur expenses, and for which operating results are regularly reviewed by the entity’s chief operating decision maker (“CODM”) to make decisions regarding resource allocation and assess performance, and for which discrete financial information is available. We determined that the Company is a single operating and reportable segment (“Products”) focused on treating the indications previously described through discovery, development, and commercialization of our novel therapeutics. Our chief executive officer acts as the CODM and allocates resources and assesses performance at a consolidated level.

 

Our Products segment measurement of profit is the consolidated loss from operations and its measure of total assets is consolidated total assets. There was no difference in our consolidated balance sheet and our segment balance sheet. Our CODM uses loss from operations predominantly in the annual budget and forecasting process to monitor variances in budget versus actual results along with consolidated total assets to determine resource allocation. The following is a summary of the significant revenue and expense categories, and net (loss) provided to the CODM during the three months ended September 30, 2025 and 2024:

                     
   For the three months
ended September 30,		   For the nine months
ended September 30,		 
Segment Results  2025   2024   2025   2024 
Revenue  $—   $80,380   $216,117   $362,691 
General & Administrative Expense (G&A)                    
Salaries, Benefits, & Insurance   181,170    183,836    504,289    547,892 
Outside Services   327,675    238,177    1,037,979    708,802 
Stock option Expense   —    40,938    —    83,747 
Facility and other overhead   44,454    30,151    126,488    100,649 
Total G&A   553,299    493,102    1,668,756    1,441,090 
Research & Development Expense (R&D)                    
Salaries, Benefits, & Insurance   205,653    229,664    865,191    679,061 
Outside Services   363,326    367,893    1,268,386    897,277 
Stock option Expense   —    338,487    —    584,983 
Facility and other overhead   151,994    110,649    372,452    389,530 
Total R&D   720,973    1,046,693    2,506,029    2,550,851 
Total operating expenses   1,274,272    1,539,795    4,174,785    3,991,941 
Loss from operations   (1,274,272)   (1,459,415))   (3,958,668)   (3,629,250)
Other income (expense)   20,194    14,778    70,581    54,658 
Segment loss from operations   (1,254,078)   (1,444,637)   (3,888,087)   (3,574,592)
Adjusting and reconciling items   —    —    —    — 
Segment Loss from operations  $(1,254,078)  $(1,444,637)  $(3,888,087)   (3,574,592)